Open-Label Study of Bioavailability of E2006 Tablet Versus Capsule Formulations
Completed · Phase 1
Conditions studied: Insomnia
In brief
This is a single-center, open-label, randomized crossover study being conducted in three cohorts of healthy adult subjects. Approximately 36 subjects will be randomized to one of three cohorts (approximately 12 subjects per cohort) and they will receive both a single dose of E2006 in capsule formulation and a single dose of E2006 in tablet formulation, in random sequence, at a 1:1 ratio. The doses to be tested will be 2.5 mg, 10 mg, and 25 mg.
Key facts
- Study ID
- NCT01673880
- Run by
- Eisai Inc.
- People needed
- 40
- Starts
- 2012-08-01
- Expected to finish
- 2012-12-01
- Last updated by the study team
- 2013-05-22
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
Where it is running
- PPD Development, LLC — Austin, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.